BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2465897)

  • 1. Treatment of human clonogenic tumor cells and bone marrow progenitor cells with bleomycin and peplomycin under 40.5 degrees C hyperthermia in vitro.
    Neumann HA; Herrmann DB; Fiebig HH; Engelhardt R
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):99-104. PubMed ID: 2465897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bleomycin and peplomycin toxicity on clonogenic tumor cells from various human tumors.
    Neumann HA; Runge HM; Fiebig HH; Engelhardt R; Löhr GW
    J Cancer Res Clin Oncol; 1986; 112(2):165-9. PubMed ID: 2429968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.
    Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
    J Natl Cancer Inst; 1985 Dec; 75(6):1059-66. PubMed ID: 2999496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytostatic drug effects on human clonogenic tumor cells and human bone marrow progenitor cells (CFU-C) in vitro.
    Neumann HA; Fiebig HH; Engelhardt R; Löhr GW
    Res Exp Med (Berl); 1985; 185(1):51-6. PubMed ID: 3969521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peplomycin and bleomycin effects on human colon cancer cells.
    Uematsu A; Ho DH; Drewinko B; Yang LY; Brown NS; Bodey GP; Krakoff IH
    Anticancer Res; 1986; 6(1):1-3. PubMed ID: 2420264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human clonogenic tumor cells.
    Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):515-23. PubMed ID: 2988968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined cell killing effects of anticancer drugs and hyperthermia in vitro].
    Nitta M; Hisazumi H; Nakajima K
    Hinyokika Kiyo; 1988 Sep; 34(9):1525-8. PubMed ID: 2463749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J; Fehér I; Kovács P
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peplomycin sensitivity of various types of human gynecological cultured tumor cells].
    Ueda M; Nozawa S; Ueki M; Sano T; Nagai S; Sugimoto O; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1867-76. PubMed ID: 6209350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal response and hyperthermic radiosensitization of scid mouse bone marrow CFU-C.
    O'Hara MD; Pollard MD; Wheatley G; Regine WF; Mohiuddin M; Leeper DB
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):905-10. PubMed ID: 7860404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
    Umbach GE; Hug V; Spitzer G; Tomasovic B; Thames H; Ajani JA; Drewinko B
    J Cancer Res Clin Oncol; 1985; 109(2):130-4. PubMed ID: 3980561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enhancement of the cytotoxicity of the bleomycin derivative, peplomycin, by local anesthetics alone and combined with hyperthermia.
    Mizuno S; Ishida A
    Cancer Res; 1982 Nov; 42(11):4726-9. PubMed ID: 6181868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal effect of bleomycin and peplomycin on HeLa cells in multicell tumor spheroids.
    Sasaki T; Yamamoto M; Kuwahara K
    Cancer Res; 1984 Apr; 44(4):1374-9. PubMed ID: 6200210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression.
    Wierenga PK; Brenner MK; Konings AW
    Bone Marrow Transplant; 1998 Jan; 21(1):73-8. PubMed ID: 9486498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
    Murphy PB; Richman CM
    Exp Hematol; 1989 Dec; 17(11):1105-9. PubMed ID: 2583254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.